Literature DB >> 20103748

FDA weighs limits for online ads.

Bridget M Kuehn.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20103748     DOI： 10.1001/jama.2009.1961

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-10

2.  Reforming direct-to-consumer advertising.

Authors:  Bryan A Liang; Tim Mackey
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

3.  Evaluation of Selective Outcome Reporting Bias in Efficacy Endpoints in Print and Television Advertisements for Oncology Drugs.

Authors:  Cole Wayant; Greg Aran; Bradley S Johnson; Matt Vassar
Journal:  J Gen Intern Med       Date:  2020-07-13       Impact factor: 5.128

4.  Layperson/Plain Language Summaries: Can Sponsors, CROs, and Sites Deliver in 2020?

Authors:  Charles S Wilcox; Leslie Franceschi; Adam Simmons
Journal:  Innov Clin Neurosci       Date:  2020-07-01

Review 5.  The role of informatics in promoting patient-centered care.

Authors:  Claire F Snyder; Albert W Wu; Robert S Miller; Roxanne E Jensen; Elissa T Bantug; Antonio C Wolff
Journal:  Cancer J       Date:  2011 Jul-Aug       Impact factor: 3.360

6.  Prevalence and Global Health implications of social media in direct-to-consumer drug advertising.

Authors:  Bryan A Liang; Timothy K Mackey
Journal:  J Med Internet Res       Date:  2011-08-31       Impact factor: 5.428
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.